Mabwell (Shanghai) Bioscience Co., Ltd. Stock
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.3 CNY | -1.97% | -3.03% | +4.93% |
May. 07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
Apr. 29 | Mabwell Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 384M 53.15M | Sales 2025 * | 1.11B 153M | Capitalization | 13.98B 1.93B |
---|---|---|---|---|---|
Net income 2024 * | -862M -119M | Net income 2025 * | -594M -82.11M | EV / Sales 2024 * | 36.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
-16.2
x | P/E ratio 2025 * |
-23.5
x | Employees | 1,491 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.33% |
1 day | +0.49% | ||
1 week | -1.07% | ||
Current month | -1.07% | ||
1 month | +5.55% | ||
3 months | +31.94% | ||
6 months | +29.26% | ||
Current year | +7.04% |
Managers | Title | Age | Since |
---|---|---|---|
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Jin Hua
DFI | Director of Finance/CFO | 43 | 23-06-26 |
Xin Du
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Ling Li
BRD | Director/Board Member | 70 | 20-10-10 |
Chun Shan Tang
BRD | Director/Board Member | 55 | 19-03-31 |
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-12 | 34.3 | -1.97% | 1 899 948 |
24-05-10 | 34.99 | +0.49% | 1,304,053 |
24-05-09 | 34.82 | -0.23% | 1,548,263 |
24-05-08 | 34.9 | -2.79% | 3,066,773 |
24-05-07 | 35.9 | -1.64% | 1,350,862 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.04% | 1.94B | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.03% | 22.25B | |
-13.14% | 22.09B | |
-7.94% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- 688062 Stock